IRMD - Company ID 0001325618
The table below shows IRADIMED CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $83.81M | $73.24M | $65.56M | $53.30M | $41.81M | $31.72M |
| Cost of revenue | $19.49M | $16.89M | $15.40M | $12.02M | $9.76M | $8.14M |
| Gross profit | $64.32M | $56.35M | $50.16M | $41.28M | $32.05M | $23.57M |
| R&D | $2.98M | $2.83M | $2.86M | $2.28M | $1.91M | $1.90M |
IRADIMED CORP reported annual revenue of $83.81M for fiscal year 2025. That is up 14.4% from $73.24M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $32.50M (FY 2016) to $83.81M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $17.78M |
| $15.94M |
| $15.12M |
| $10.70M |
| $9.77M |
| $12.27M |
| Operating income | $26.15M | $21.96M | $20.04M | $15.63M | $9.82M | -$756.09K |
| Income tax | $5.88M | $5.04M | $4.55M | $3.35M | $510.82K | -$1.99M |
| Net income | $22.48M | $19.23M | $17.19M | $12.83M | $9.33M | $1.37M |
| EPS (diluted) | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 | $0.11 |